Clinical Trials · NCT01938820
Optimized Treatment and Regression of HBV-induced Early Cirrhosis
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Beijing Friendship Hospital
- Enrollment
- 82
- Start date
- Jun 2013
- Locations
- 21 sites, China
- Primary endpoint
- Regression of HBV-induced liver cirrhosis